Xeris Biopharma Holdings, Inc. (XERS)
Xeris Biopharma Holdings Market Cap : 3.031B for Nov. 19, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 3.102B |
| November 17, 2026 | 3.067B |
| November 16, 2026 | 3.049B |
| November 13, 2026 | 3.042B |
| November 12, 2026 | 3.040B |
| November 11, 2026 | 3.016B |
| November 10, 2026 | 2.890B |
| November 09, 2026 | 2.896B |
| November 06, 2026 | 2.775B |
| November 05, 2026 | 2.388B |
| November 04, 2026 | 1.910B |
| November 03, 2026 | 1.890B |
| November 02, 2026 | 1.765B |
| October 30, 2026 | 1.859B |
| October 29, 2026 | 1.866B |
| October 28, 2026 | 1.847B |
| October 27, 2026 | 1.814B |
| October 26, 2026 | 1.772B |
| October 23, 2026 | 1.771B |
| October 22, 2026 | 1.885B |
| October 21, 2026 | 1.872B |
| October 20, 2026 | 1.932B |
| October 19, 2026 | 1.901B |
| October 16, 2026 | 1.790B |
| October 15, 2026 | 1.748B |
| Date | Value |
|---|---|
| October 14, 2026 | 1.696B |
| October 13, 2026 | 1.771B |
| October 12, 2026 | 1.816B |
| October 09, 2026 | 1.819B |
| October 08, 2026 | 1.769B |
| October 07, 2026 | 1.755B |
| October 06, 2026 | 1.748B |
| October 05, 2026 | 1.758B |
| October 02, 2026 | 1.576B |
| October 01, 2026 | 1.606B |
| September 30, 2026 | 1.660B |
| September 29, 2026 | 1.732B |
| September 28, 2026 | 1.706B |
| September 25, 2026 | 1.580B |
| September 24, 2026 | 1.554B |
| September 23, 2026 | 1.503B |
| September 22, 2026 | 1.515B |
| September 21, 2026 | 1.528B |
| September 18, 2026 | 1.423B |
| September 17, 2026 | 1.417B |
| September 16, 2026 | 1.351B |
| September 15, 2026 | 1.300B |
| September 14, 2026 | 1.314B |
| September 11, 2026 | 1.293B |
| September 10, 2026 | 1.331B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Ligand Pharmaceuticals, Inc. | 5.744B |
| MBX Biosciences, Inc. | 2.654B |
| ANI Pharmaceuticals, Inc. | 1.581B |
| Corcept Therapeutics, Inc. | 7.119B |
| Veru, Inc. | 36.66M |
Market Cap Related Metrics
| PS Ratio | 8.119 |
| Price to Book Value | 62.12 |
| Price to Free Cash Flow | 41.17 |
| Price | 16.60 |
| Earnings Yield | -0.28% |
| Operating PE Ratio | 63.91 |
| Normalized PE Ratio | 212.01 |